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Peripheral blood lymphocytes from patients with chronic lymphocytic leukemia (CLL) acquire after several 
days of exposure to 12-~-tetrad~anoylpho~l-l3-a~tate (TPA) several mo~holo~cal, immunolo~~l and 
histochemical features of hairy cell leukemia. We have investigated the short term effects of TPA treatment 
on protein kinase C and its subcellular distribution. Within minutes of addition of TPA to CLL cells 20% 
of the cytosolic protein kinase C had associated with the particulate fraction. The remaining 80% of protein 
kinase C activity was down-regulated. The association with the membrane dramatically increased the resist- 
ance of the enzyme to inhibition by the non-ionic detergent, Triton X-180. These results suggest hat activa- 
tion of protein kinase C causes multiple biological changes in CLL cells. 
Chronic lymphocyti~ leukemia Protein kinase C Tumor promoter 
1. INTRODUCTION 
The tumor-promoting phorbol esters cause a 
variety of biological effects in different systems 
[l-4]. Treatment with TPA stimulates conversion 
of cells from patients with CLL to plasmacytoid 
cells showing many of the characteristics of hairy 
cell leukemia [5,6]. The biological effects of TPA 
are mediated via protein kinase C, a phospholipid- 
and calcium-dependent enzyme [7]. This enzyme is 
activated by diacylglycerol produced by receptor- 
stimulated breakdown of membrane inositol 
lipids. Phorbol esters bypass this step by sub- 
stituting for diacylglycerol [7,8]. We show here 
that TPA treatment of cells from CLL patients 
results in the rapid disappearance of the bulk of 
the cytosolic kinase C activity. The remainder (ap- 
prox. 20%) associates transiently with the par- 
ticulate fraction. This association dramatically in- 
Abbreviations: CLL, chronic lymphocytic leukemia; 
TPA, 12-0-tetradecanoylphorbol-13-acetate 
creases the resistance of the enzyme to inhibition 
by the non-ionic detergent, Triton X-100. 
2. MATERIALS AND METHODS 
Peripheral blood lymphocytes from patients 
with CLL were isolated by centrifugation on Lym- 
phoprep gradients (Nyegaard, Norway) and cul- 
tured in RPM1 1640 medium containing 10% fetal 
calf serum. Cytosolic and 100 000 x g particulate 
fractions were prepared as described [9]. Protein 
kinase C assays were carried out according to 
Parker et al. [lo]. Kinase C was quantitated by its 
ability to transfer radiolabel from [Y-~‘P]ATP to 
histone in the presence but not in the absence of 
phosphatidylserine. 
3. RESULTS AND DISCUSSION 
In each experiment described here, TPA-induced 
conversion of CLL cells was routinely monitored 
by morphological and immunological criteria 
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described previously [5,6]. After 3 days of treat- 
ment with 16 nM TPA, CLL cells had lost their 
characteristic lymphocytoid appearance. Over 
9090 of the cells exhibited protrusions and mem- 
brane ruffles. Twenty to 50% of the cells showed 
one or two protrusions which were 5-&times the 
length of the cell. After 24 h treatment with TPA, 
>80% of the cells had lost surface immuno- 
globulin, whereas cytoplasmic immunoglobulin (of 
the same light chain class present on untreated 
cells) was clearly detected. None of these changes 
were seen in cultures to which TPA was not added. 
In addition, B lymphocytes from non-leukemic 
subjects did not undergo these changes when 
treated with TPA. 
Cytosolic protein kinase C disappeared rapidly 
when CLL cells were treated with 16 nM TPA 
(fig.la). The specific activity of this enzyme was 
16 300 units - mg-” protein in untreated cells and 
fell to 60 units. mg-’ within 10 min of TPA addi- 
tion (1 unit is the incorporation of 1 pmol 32P04 
into histone per 5 min). To determine the fate of 
the enzyme, we assayed particulate fractions 
prepared from the same cell samples. No activity 
was detected at any time using the standard assay. 
However, the inclusion of 0.25% Triton X-100 in 
the reaction enabled the detection of kinase C ac- 
tivity in particulate fractions from TPA-treated 
cells [I 11. Fig. lb shows a rapid rise in particulate- 
bound kinase C, peaking at 30 min, then declining 
slowly. 24 h after TPA addition, no activity re- 
mained in this fraction (not shown). The increase 
in specific activity in the particulate fraction was 
rapid and dramatic, rising from 200 units - mg-’ in 
untreated cells to 12 300 units - mg-’ 30 min after 
TPA addition. Similar results were obtained using 
cells from three different CLL patients. We also 
observed that less than 5070 of cellular kinase C ac- 
tivity was recovered in the nuclear fraction, both 
before and after TPA treatment (not shown). 
However, when absolute amounts of protein 
kinase C activity (expressed as nmol . min-* . 10' 
cell equiv .- ‘) as opposed to specific activity (ex- 
pressed as units - mg protein-‘) in the particulate 
and cytosolic fractions were quantitated, only 20% 
of the kinase C activity lost from the cytosol was 
recovered in the particulate fraction (cf. fig.la and 
b). Since we observed that the cytosolic form of the 
enzyme was totally inhibited in the presence of 
0.25% Triton X-100 (table 2, expt l), we wished to 
investigate whether this detergent exerted a dual ef- 
fect on the particulate enzyme, increasing its access 
to substrates but at the same time inhibiting in the 
assay by a separate mechanism. Therefore, Triton 
X-100 treated particulate kinase C was separated 
from the detergent and solubilized membrane lipid 
by chromatography on a column of DEAE cellu- 
lose. Fig.2 shows that the enzyme was bound by 
tkdmin) 
Fig.1. Changes in cytosolic and particulate forms of protein kinase C following TPA treatment of CLL cells. Kinase 
C activity was assayed in cytosolic (panel a) and particulate (panel b) fractions prepared from the cells of the indicated 
intervals following addition of TPA to cultures: Triton X-100 (0.25%) was inclused in assays of particulate fractions. 
e, 16 nM TPA added; Q, control. 
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fraction no 
the column and was eluted by 0.1 M NaCl. The 
column load contained 10634 units of activity 
(assayed in the presence of 0.25% Triton X-100) 
Fig.2, DEAE cellulose chromatography of protein 
kinase C from the particulate fraction of TPA-treated 
CLL cells. A particulate fraction was incubated for 1 h 
at 4’C in the presence of 1% Triton. The enzyme was 
adsorbed to a column of DEAE cellulose and eluted with 
buffer containing 0.1 M NaCl [lO,l 11. The arrow in- 
dicates commencement of this elution. Aliquots (5 pl) 
were assayed for kinase C activity in the presence (0) or 
absence (0) of phosphatidylserine (A), assay carried out 
in the presence of 0.25% Triton X-100. 
whereas 14300 units were recovered in the eluate 
(134% recovery). Since there was no dramatic in- 
crease in enzyme activity after the column step and 
since cytosolic kinase C inhibition by Triton X-100 
is fully reversible by DEAE cellulose chroma- 
tography (table 1, expt I), we conclude that assay 
of particulate fractions in the presence of Triton 
X-100 gives a true value for this form of the en- 
zyme. Fig.2 also confirms the identity of the par- 
Table 1 
Properties of cytosolic and particulate forms of protein kinase C 
Enzyme fraction Protein kinase C activity (pm01 .5 
min-‘) 
- Triton X-100 + 0.25% Triton 
x-100 
Experiment 1 
(a) (0.25 ml cytosol from untreated cells 
(b) as (a) above, after incubation with 0.25% 
Triton X-100 and subsequent chromatography on 
DEAE cellulose 
Experiment 2 
(a) 2.5 pl cytosol from control cells 31 ND 
fb) 2.5 pl cytosol from TPA-treated cells 4 ND 
(c) (a) plus (b) 39 ND 
Experiment 3 
(a) 2.5 pl particulate fraction from control cells 
(b) 2.5 yl particulate fraction from TPA-treated 
cells 
(c) (a) plus (b) 
Experiment 4 
(a) 2.5 pl cytosol from control cells 
(b) 2.5 pl particulate fraction from TPA-treated 
cells 
(c) (a) plus (b) 
4100 
5200 
ND 1.2 
ND 49 
ND 48 
46 
2 
51 
112 
0 
1.5 
50 
42 
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ticulate form of the enzyme as protein kinase C 
since the elution behaviour and the total depend- 
ence of activity on phosphatidylserine are charac- 
teristics of authentic kinase C [lo, 111. 
We then eliminated the possibility that the TPA- 
induced effects were due to changes in the concen- 
tration of inhibitors or to changes in their sub- 
cellular distribution. Mixing of either active and 
inactive cytosolic fractions or active and inactive 
particulate fractions gave additive yields in the 
assay (table 1, expts 2 and 3). Furthermore, DEAF 
cellulose chromatography of a cytosolic prepara- 
tion from TPA-treated cells failed to reveal any 
cryptic kinase C activity, also suggesting that no 
inhibitors were present in this preparation (not 
shown). 
The rapid appearance of kinase C activity in the 
particulate fraction of TPA-treated cells might be 
explained if the drug bound to the particulate frac- 
tion and activated kinase C molecules already pre- 
sent (but undetectable) in this fraction. However, 
addition of TPA to 16 nM or to 160 nM to the in 
vitro assay did not activate kinase C activity in 
either particulate or cytosolic fractions from con- 
trol or TPA-treated cells (not shown). This was not 
surprising, since TPA activates kinase C by reduc- 
ing its calcium requirement so that it can function 
at the low intracellular calcium levels (about lo-’ 
M) existing in normal cells [7,8]. At the levels of 
Ca2+ used in our assay (1.5 mM) no further activa- 
tion of kinase C by TPA would thus have been ex- 
pected. 
We then investigated the pharmacological speci- 
ficity of the effect of phorbol esters. Phorbol-13- 
monoacetate, which unlike TPA, lacks a diacyl- 
glycerol-like moiety, failed to induce the long-term 
biological responses produced by TPA. No changes 
in the subcellular distribution or activity of protein 
kinase C occurred, confirming the absolute depend- 
ence of the TPA effect on its diacylglycerol struc- 
ture. 
The results described here show that treatment 
of CLL cells with TPA leads to a rapid and exten- 
sive decrease of protein kinase C activity. Almost 
all of the kinase activity in untreated CLL cells was 
recovered in the cytosolic fraction. Upon treat- 
ment with TPA a small but reproducible propor- 
tion (approx. 20%) of this activity was trans- 
located to the 100000 x g particulate fraction, 
whereas the remainder was down-regulated. Our 
results differ significantly from those reported 
earlier by Kraft and Anderson [ 121, since in their 
study treatment of parietal yolk sac cells led to 
almost complete translocation of kinase C from 
the cytosol to the particulate fraction with no 
evidence of down-regulation. It must be pointed 
out that in their study Kraft and Anderson did not 
report any biological consequence of TPA treat- 
ment on the target cells. In this work conversion of 
CLL cells to cells with many of the phenotypic 
characteristics of hairy cells was clearly demon- 
strated. Rapid down-regulation of proteins involved 
in signal transduction following receipt of the 
signal is a well documented phenomenon. For ex- 
ample; the receptors for several growth factors are 
rapidly internalized and degraded following the 
binding of the appropriate factors 113-151. This is 
consistent with a role for protein kinase C in 
transducing the TPA signal in the present system. 
Protein kinase C activity of 3T3 mouse fibro- 
blasts was also shown to be down-regulated in 
response to treatment of the intact cells with phor- 
bol ester [16]. However, down-regulation in this 
case was slow, with a half-life of 6-7 h, whereas 
the effects reported in the present work were com- 
plete within 10 min. Furthermore, no redistribu- 
tion of enzyme between cellular compartments 
could be demonstrated in the 3T3 system, since 
detergent lysates of whole cells were used for 
assay. The marked difference in the kinetics of 
phorbol ester-induced kinase C down-regulation in 
3T3 cells and in human CLL cells may be related 
to the differences in biological responses elicited in 
the two systems; phorbol esters are co-mitogenic 
with growth factors in the 3T3 system [17], where- 
as they induce differentiation-like changes in CLL 
cells. 
Finally, we observed a striking difference in 
properties between the cytosolic and particulate 
forms of the enzyme. The cytosolic form of kinase 
C was totally inhibited by the presence in the assay 
of 0.25% Triton X-100. This was not due to an ir- 
reversible action of detergent on the enzyme, since 
DEAE cellulose chromatography of Triton-treated 
cytosolic kinase C led to complete recovery of the 
enzyme (table 2, expt 1). In contrast, the par- 
ticulate form of the enzyme was dramatically ac- 
tivated by 0.25% Triton X-100, probably due to 
the solubilization of membranes. The resistance of 
the particulate enzyme cannot be explained simply 
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by the presence in the reaction mixture of solubil- 
ized components from the particulate fraction, 
since cytosolic kinase C mixed with a particulate 
fraction and then assayed in the presence of Triton 
X-100 was also inhibited (table 1, expt 4). It is thus 
likely that the detergent resistance of particulate 
kinase C was due to a specific association with a 
component of the particulate fraction. This com- 
ponent can be separated from particulate kinase C 
by ion-exchange chromatography since the resul- 
tant enzyme fraction was completely inhibited by 
Triton X-100 (fig.2). We will attempt in future 
studies to identify the stabilizing component with 
the expectation that this will help to elucidate the 
mechanism by which protein kinase C mediates the 
phorbol ester signal for differentiation of CLL 
cells to cells resembling hairy cells. An under- 
standing of this mechanism may have therapeutic 
consequences, ince hairy cell leukemia appears to 
be amenable to treatment with interferon [18], 
whereas CLL typically is not responsive to in- 
terferon [ 191. 
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